A FREE RIDE OFF OF THE INVESTMENTS OF INNOVATORS
PhRMA pushes for European Union to be added to USTR’s priority watch list
By Mari Serebrov
Friday, February 14, 2014
If brand drugmakers have their way, the EU could be counted among the countries and regions that are the worst in undermining the value of U.S. companies’ intellectual property rights.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.